DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment

 

 

Molecular Imaging Homepage

ITM enters North American partnerships to establish stable n.c.a.-Lutetium-177 supply Enhance use and supply for targeted radionuclide therapy

Generator production for Tc-99m in Australia suspended following mechanical fault Expected to take weeks to repair

James Allison, Padmanee Sharma and Ramy Ibrahim ImaginAb appoints new members to scientific advisory board

Alliance completes deal for Piramal Imaging Expanding market presence in molecular imaging

Siemens announces first global installation of Biograph Vision PET/CT System yields better temporal resolution and sensitivity than previously reported

Cardinal Health showcases first integrated cloud solution for nuclear medicine at SNMMI Nuctrac replaces phone and fax orders

New PET tracer could help find cure for Alzheimer's Researchers from Yale show they can measure synaptic density: SNMMI

Spectrum Dynamics launches 12 detector SPECT system The VERITON SPECT system debuted at SNMMI

GE launched Syntermed's Emory Cardiac Toolbox at SNMMI Affordable option for users with older SPECT systems

Combined radionuclide therapy and immunotherapy shows promise New research unveiled at SNMMI meeting

Could be used for other
mental disorders

Researchers develop PET tracer that may predict effectiveness of depression treatment

por Lauren Dubinsky , Senior Reporter
A new PET tracer can determine ahead of time whether a drug can successfully treat major depressive disorder (MDD), according to a study published in the April issue of The Journal of Nuclear Medicine.

“In this study we use a PET tracer that targets the serotonin transporter, an important protein within the serotonergic system,” Dr. Mala R. Ananth of Stony Brook University in New York, told HCB News. “Dysfunction of the serotonergic system is a common hypothesis for the underlying cause of MDD.”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



In clinical psychiatry, there are currently no objective markers to predict if a treatment will be effective. 11C-DASB PET imaging could change that.

The drug escitalopram, which is a selective serotonin reuptake inhibitor (SSRI), has been shown to be an effective treatment for MDD, but it doesn’t work for every patient. A 11C-DASB PET scan can determine which patients will benefit by measuring the level of serotonin transporter protein present before treatment.

Ananth and her team had 31 healthy participants and 26 untreated patients with MDD receive a 11C-DASB PET scan. The MDD patients then underwent eight weeks of standardized therapy with escitalopram.

They found that patients who responded well to the treatment had less serotonin transporter proteins before treatment began. This suggests that pre-treatment neurobiology could be used to predict treatment response.

“Here we find that patients with MDD who achieve remission following treatment with a specific SSRI (escitalopram) exhibit differences in the serotonin transporter in a region important for emotional processing prior to treatment,” said Ananth.

She added that these findings may be applicable for any disorder in which SSRIs are used, including obsessive-compulsive disorder, but that further research is needed to confirm that.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS